The Atopic Dermatitis Control Tool: What Six Questions Can Add to an Eczema Appointment

Doctor’s Notes · Eczema Research · November 2026

A brief appointment may not show what eczema did to the rest of your week. The Atopic Dermatitis Control Tool, or ADCT, was developed to capture patient-perceived control rather than only the appearance of the rash. It can organize a conversation about how care is working in daily life.

A control measure has a particular purpose

The development report described a six-item tool with seven-day recall and identified a score of seven or more as an optimal threshold for disease not in control in the studied population. It evaluated measurement properties, not a new treatment. Separate longitudinal validation studied biologic-treated patients. Validation supports use of the tool in appropriate settings; it does not mean a score can replace a clinical assessment.

Prepare the week, not a perfect answer

Ask your care team for the appropriate official version and scoring instructions rather than copying an improvised questionnaire. Think about the same recent period each time. A difficult work shift, missed activity or disrupted night can provide context for a score. The goal is to describe your experience accurately, not to obtain a number you think the clinician wants.

Keep signs, symptoms and control distinct

A small visible area may still have a large effect on a particular task, while a photograph cannot record every nighttime symptom. Conversely, an improved week does not necessarily mean all inflammation has resolved. Discuss the score alongside examination and the treatment history. Different tools can answer different questions without one being wrong.

Use the result to agree on a review plan

Ask what changes would lead to reassessment and what improvement would matter to you. Do not increase or stop prescribed medicines simply because a score crosses a threshold. For an active or busy adult, a short measure is most useful when it helps the care team address a concrete obstacle and track a clear goal over time.

Related care questions include what does eczema control mean? reading the recap questionnaire and an eczema flare diary that helps your dermatologist. Keep each question connected to its own symptoms, exposure and evidence.

Dr. Arsy #003 in this discussion

Dr. Arsy #003 provides cosmetic hydration and moisture-barrier support where suitable. It was not established as an eczema-control treatment by these ADCT studies. A product's place in the routine should follow its current package, individual tolerance and the medical plan—not a claim that a questionnaire validates the cream.

For a fuller picture of measurement, compare the HOME core-outcome framework and patient–clinician severity disagreement.

Sources and further reading

1. Primary research record, PubMed
2. Additional research report

Dr. Arsy Editorial Team. General education, not independent medical review. Discuss diagnosis and treatment with a qualified clinician. #003 is cosmetic moisture care, not an eczema medicine. Image is an AI-generated scene based on the actual product jar. PubMed indexing does not imply NIH endorsement.